Jun 2024

Enhancing Patient Satisfaction through BAK-Free Solutions: Dr. Miriam Kolko's Vision for Preservative-Free Eye Care

In this episode, Miriam Kolko, MD, PhD, shares her vision for preservative-free eye care. Dr. Kolko strongly advocates for patient education regarding the benefits and limitations of preservative-free alternatives, encouraging tailored treatment strategies. Ultimately, she envisi ... Show More

12m 7s

Jun 2024

Unveiling the Paradox: BAK's Role in American Pharmaceuticals With Dr. Nate Radcliffe

In this episode, Nathan Radcliffe, MD, discusses the widespread use of benzalkonium chloride (BAK) in the US ophthalmic market. Dr. Radcliffe acknowledges concerns about its long-term effects, such as exacerbating dry eye and impacting the success of incisional glaucoma surgery. ... Show More

11m 24s

Jun 2024

The European Approach to Preservative-Free Pharmaceuticals: A Conversation With Dr. Anton Hommer

In this episode, Anton Hommer, MD, discusses the European perspective on adopting preservative-free pharmaceuticals, highlighting challenges like health care professionals’ reluctancy to change, diverse reimbursement systems, and higher costs. He compares single-use and multiuse ... Show More

11m 50s

Apr 2023

Eye Health

Joan Buckley learns about how to keep your eyes healthy - and what happens when things aren’t so clear, pun intended, with Dr. Daniel Laroche, the Director of Glaucoma Services, and President, of Advanced Eyecare of New York. He is affiliated with the New York Eye and Ear Infirma ... Show More

28m 19s

Apr 2025

Glaucoma Medications and Risk of Uveitis

Dr. Edmund Tsui interviews authors Dr. Muhammad Z. Chauhan and Dr. Krishna S. Kishor on the risk of uveitis among patients starting topical glaucoma therapy. From their Ophthalmology Glaucoma article, "<a href= "https://www.ophthalmologyglaucoma.org/ ... Show More

17m 1s

Nov 2021

Newer Nonsurgical Treatment Options for Glaucoma

Drs. Lorraine Provencher and Matthew Emanuel join the show to discuss current nonsurgical management options for glaucoma patients. The panel reviews new topical therapy such as rho kinase (ROCK) inhibitors, injectable therapy, and the role of selective laser trabeculoplasty (SLT ... Show More

35m 26s

Jul 2022

Is Pharmacology Difficult Podcast ATROPINE & ALTERNATIVE DRUGS/SUBSTITUTES-3

Welcome all to IS PHARMACOLOGY DIFFICULT Podcast! I am Dr Radhika Vijay.In today's eye to eye talk, I show a great concern for your eyes and describe the Effects and Uses of Atropine and Congener drugs/ Substitute drugs on Eyes and associated structures. I will be covering Atropi ... Show More

10m 53s

Jul 2021

Eye to Eye Ophthalmology: How to reduce the risk of endophthalmitis in patients attending for intravitreal injections

In this episode we speak with Quresh Mohamed, a Consultant Ophthalmologist from Cheltenham. We discuss his paper entitled, 'Post-injection endophthalmitis rates with reduced povidone-iodine prophylaxis in patients with self-reported iodine sensitivity'.

33m 12s

Jun 2024

Knock Knock Eye: What Happens When Toxicology Meets Ophthalmology?

In this episode of Knock Knock Eye, I welcome Dr. Josh Trebach to explore the intersection of toxicology and ophthalmology. Discover how various toxins affect the eyes, hear captivating stories from the ER, and learn about the dangers of common plants and chemicals in this engagi ... Show More

44m 33s

Aug 2024

Optimizing Dry Eye Management for Cataract Surgery

In this episode of CRST: The Podcast, host Kenneth Beckman, MD, FACS, speaks with Priya M. Mathews, MD, MPH, about the critical role of dry eye management in cataract surgery. They discuss the importance of optimizing the ocular surface before surgery to ensure premium outcomes, ... Show More

29m 31s

Jul 2023

Low-Dose 0.01% Atropine Eye Drops vs Placebo for Myopia Control

Interview with Michael X. Repka, MD, MBA, author of Low-Dose 0.01% Atropine Eye Drops vs Placebo for Myopia Control: A Randomized Clinical Trial. Hosted by Neil Bressler, MD. Related Content: Low-Dose 0.01% Atropine Eye Drops vs Placebo for Myopia Control

13m 11s

Feb 2024

397. Glaucoma

This is the 2nd episode in a 5-part eye series. This episode is brought to you by Kim Papp, a 4th year medical student at the University of Alberta. Today we will discuss glaucoma and learn the basics of this common ocular disease. By the end of this podcast the listener will be ... Show More

17m 6s

May 2023

29: Hydroxychloroquine – Potentially toxic, potentially blinding

One of the side-effects for patients who take hydroxychloroquine, or chloroquine, can be retinal toxicity. The drug is usually taken to help treat rheumatic disorders, but around 7.5% of people who take hydroxychloroquine for over five years are thought to develop retinopathy. Th ... Show More

27m 59s

Navigating the Impact of Preservatives i...